Skip to main content

Future Challenges and Opportunities to Improve Outcomes for Children with Leukemia

  • Chapter
  • First Online:
Childhood Leukemia

Part of the book series: Pediatric Oncology ((PEDIATRICO))

  • 2147 Accesses

Abstract

The past 50 years have seen remarkable progress in improving the survival of children with cancer (Smith et al. 2010). Among the greatest of these successes are the outcomes for children with acute leukemia. To better understand the incidence and survival for children with all cancers, including leukemia, a comprehensive analysis was recently performed in the United States using the Surveillance, Epidemiology, and End Results 9 (SEER 9) Registry (Smith et al. 2010). This data showed an increased incidence rate for all cancers in children less than 20 years of age during the years 1975 through 2006 (Fig. 13.1). The incidence rates for lymphoid leukemia increased significantly during this time period, with an annual percentage change of 0.8%. Mortality rates for all childhood cancers combined declined by more than 50%, with an estimated 38,032 childhood cancer deaths averted in the United States during this 31-year time period (Fig. 13.2). Remarkably, there was a 64% reduction in mortality rates attributable to leukemia. However, despite these significant reductions in leukemia-specific mortality rates, death due to leukemia remained the leading cause of cancer death in children in both 1975 and in 2006.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Arico M, Valsecchi MG et al (2000) Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 342(14): 998–1006

    Article  PubMed  CAS  Google Scholar 

  • Druker BJ, Sawyers CL et al (2001) Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344(14):1038–1042

    Article  PubMed  CAS  Google Scholar 

  • Gaynon PS, Trigg ME et al (2000) Children’s Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995. Leukemia 14(12):2223–2233

    Article  PubMed  CAS  Google Scholar 

  • Harvey RC, Mullighan CG et al (2010) Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leu-kemia. Blood 115(26): 5312–5321

    Google Scholar 

  • Insitute of Medicine (2010) A national cancer clinical trials system for the 21st century: reinvigorating the NCI cooperative group program

    Google Scholar 

  • Maloney KW, Shuster JJ et al (2000) Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986–1994. Leukemia 14(12):2276–2285

    Article  PubMed  CAS  Google Scholar 

  • Mauro MJ, O’Dwyer M et al (2002) STI571: a paradigm of new agents for cancer therapeutics. J Clin Oncol 20(1): 325–334

    Article  PubMed  CAS  Google Scholar 

  • Mullighan CG, Miller CB et al (2008) BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453(7191):110–114

    Article  PubMed  CAS  Google Scholar 

  • Mullighan CG, Collins-Underwood JR et al (2009a) Re-arrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet 41(11):1243–1246

    Article  PubMed  CAS  Google Scholar 

  • Mullighan CG, Su X et al (2009b) Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 360(5): 470–480

    Article  PubMed  CAS  Google Scholar 

  • Mullighan CG, Zhang J et al (2009c) JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 106(23):9414–9418

    Article  PubMed  CAS  Google Scholar 

  • Savage DG, Antman KH (2002) Imatinib mesylate – a new oral targeted therapy. N Engl J Med 346(9):683–693

    Article  PubMed  CAS  Google Scholar 

  • Schultz KR, Bowman WP et al (2009) Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children’s oncology group study. J Clin Oncol 27(31): 5175–5181

    Article  PubMed  CAS  Google Scholar 

  • Smith MA, Seibel NL et al (2010) Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28(15):2625–2634

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gregory H. Reaman .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Reaman, G.H., Smith, F.O. (2011). Future Challenges and Opportunities to Improve Outcomes for Children with Leukemia. In: Reaman, G., Smith, F. (eds) Childhood Leukemia. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13781-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-13781-5_13

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-13780-8

  • Online ISBN: 978-3-642-13781-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics